Aurobindo Pharma Shares Drop 2.5% After USFDA Issues 10 Observations to Telangana API Unit
Shares of Aurobindo Pharma Ltd. fell by 2.5% after reaching a day’s high of Rs 1,518.90 on 30th September, following the company’s announcement that the...
Tag : Aurobindo Pharma
Aurobindo, Alembic Shares Slide as They Recalled Drugs from US Markets
Alembic Pharmaceuticals and Aurobindo Pharma issued voluntary recalls of different products in the US markets because of quality issues and manufacturing deficiencies, according to the...
Aurobindo Pharma Arm Enters into an Agreement with US Company; Shares Prices Fell
Aurobindo Pharma’s share price plunged and turned red on July 10 after its wholly-owned subsidiary CuraTeQ Biologics announced that it has entered into an exclusive...
Aurobindo Pharma Hits 52-Week High, Shares Up 63% from February Lows on Improved Earnings
Shares of Aurobindo Pharma surged 5% in intraday trade on Tuesday, hitting a 52-week high of Rs 646.35 on the BSE on heavy volume. The...
Aurobindo Pharma Jumps 5% After Subsidiary Gets USFDA Nod for Osteoarthritis Pain Reliever
Shares of Aurobindo Pharma soared nearly 6% in the afternoon session on February 8 after the drugmaker said its downline subsidiary Aurolife Pharma had been...
Aurobindo Pharma Trades in Red Despite FDA Approval of Eugia Pharma Injection
Aurobindo Pharma posted a small loss on January 4 amid weaker markets. At 12:01 pm, Aurobindo Pharma was quoted at Rs 440.20, below Re 1,...
Aurobindo Pharma Rises on Bargain Hunting
Aurobindo Pharma gained 1.35 per cent to Rs 462.40 on bargain hunting. The stock dropped 7.21 per cent in seven days of trading sessions at...
Aurobindo Pharma Arm Gets USFDA Approval for Fungal Infection Treatment Injection
Aurobindo Pharma said on Friday that its wholly-owned subsidiary Eugia Pharma Specialties had received final approval from the United States Food and Drug Administration (USFDA)...
Nifty Drops Below 18,250 Level
In the domestic market, barometers extended losses and hit fresh trade low in the morning trade. The Nifty traded tad below the 18,250 level. Also,...
Aurobindo Pharma Hits Over 2-Year Low on Weak Q2 Results
Aurobindo Pharma’s shares went down by 7 per cent to hit an over last two years below Rs 457.20 on the Bombay Stock Exchange (BSE)...